Pre-earnings options volume in Adma Biologics (ADMA) is 1.7x normal with puts leading calls 7:6. Implied volatility suggests the market is anticipating a move near 10.9%, or $2.58, after results are released. Median move over the past eight quarters is 9.2%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA:
- ADMA Biologics Inc (ADMA) Q1 Earnings Cheat Sheet
- Amazon sellers pull away from Prime Day, IBM to invest in U.S.: Morning Buzz
- Adma announces U.S. FDA approval of production yield enhancement process
- Biotech Alert: Searches spiking for these stocks today
- ADMA Biologics reiterates ‘strategic advantage’ through U.S.-based manufacturing